Cardiometabolic risk reduction after metabolic surgery.
Curr Opin Cardiol
; 34(6): 663-672, 2019 11.
Article
em En
| MEDLINE
| ID: mdl-31524661
PURPOSE OF REVIEW: Metabolic surgery provides the largest and most durable weight loss in persons with obesity. There is abundant randomized evidence to show its superiority over medical treatment alone in achieving improved glycemic control. RECENT FINDINGS: Recent trials have also demonstrated a significant reduction in cardiovascular risk factor burden, whereas data from observational studies suggest an ability to reduce overt cardiovascular events and mortality. SUMMARY: In this review, we briefly describe the surgical procedures involved and their indications. We further provide a summary of the effects of metabolic surgery on weight loss, glycemic control, and clinical outcomes.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Diabetes Mellitus Tipo 2
/
Cirurgia Bariátrica
/
Obesidade
Tipo de estudo:
Clinical_trials
/
Etiology_studies
/
Guideline
/
Observational_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Revista:
Curr Opin Cardiol
Assunto da revista:
CARDIOLOGIA
Ano de publicação:
2019
Tipo de documento:
Article